This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ginocchio, C. C.
Right arrow Articles by Carroll, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ginocchio, C. C.
Right arrow Articles by Carroll, R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Nov 1997, 2886-2893, Vol 35, No. 11
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma [In Process Citation]

CC Ginocchio, XP Wang, MH Kaplan, G Mulligan, D Witt, JW Romano, M Cronin and R Carroll
Department of Medicine, North Shore University Hospital, Manhasset, New York 11030, USA. cginocch@nshs.edu

To define the optimal blood collection parameters for plasma human immunodeficiency virus type 1 (HIV-1) viral load testing, plasma HIV-1 RNA levels were quantitated with the NASBA HIV-1 RNA QT System from blood specimens that were collected, processed, and stored under a variety of conditions that might have affected HIV-1 RNA stability. We determined that when whole blood was processed within 2 h of specimen collection the levels of HIV-1 RNA detected in EDTA-, heparin-, and acid citrate dextrose (ACD)-anticoagulated plasma samples were comparable. The levels of HIV-1 RNA in serum specimens (mean = 4.126 log units) were significantly lower (P < 0.01) than the levels in corresponding plasma samples (mean = 4.501 log units). One cycle of freeze-thaw (-70 degrees C) did not significantly reduce the level of HIV-1 RNA detected in EDTA-, heparin-, or ACD-anticoagulated plasmas. The EDTA-anticoagulated plasmas showed the smallest decrease in HIV-1 RNA copies (0.050 log units). HIV-1 RNA levels decreased over a 6-month time period in serum as well as in EDTA-, ACD-, and heparin- anticoagulated plasmas stored at -70 degrees C. However, the only significant decreases were for serum (mean decrease = 0.317 log units) and heparin-anticoagulated samples (mean decrease = 0.384 log units). A comparison of the levels of HIV-1 RNA in cell-free plasma collected in VACUTAINER EDTA Plasma Preparation Tubes and in standard VACUTAINER EDTA tubes determined that HIV-1 RNA levels were stable for up to 30 h after collection when stored at either room temperature (mean standard deviation [SD] = +/- 0.101 log units) or at 4 degrees C (mean SD = +/- 0.102 log units) as cell-free plasma or as EDTA-anticoagulated whole blood (mean SD = +/- 0.109 log units). These data indicate that EDTA- anticoagulated plasma is the most suitable and stable matrix for HIV-1 RNA quantitation.


This article has been cited by other articles:

  • Stewart, M., Desport, M., Hartaningsih, N., Wilcox, G. (2005). TaqMan Real-Time Reverse Transcription-PCR and JDVp26 Antigen Capture Enzyme-Linked Immunosorbent Assay To Quantify Jembrana Disease Virus Load during the Acute Phase of In Vivo Infection. J. Clin. Microbiol. 43: 5574-5580 [Abstract] [Full Text]  
  • Marteau, J.-B., Mohr, S., Pfister, M., Visvikis-Siest, S. (2005). Collection and Storage of Human Blood Cells for mRNA Expression Profiling: A 15-Month Stability Study. Clin. Chem. 51: 1250-1252 [Full Text]  
  • Ghosh, M. K., Kuhn, L., West, J., Semrau, K., Decker, D., Thea, D. M., Aldrovandi, G. M. (2003). Quantitation of Human Immunodeficiency Virus Type 1 in Breast Milk. J. Clin. Microbiol. 41: 2465-2470 [Abstract] [Full Text]  
  • Jennings, C., Bremer, J. W., Brambilla, D. J. (2000). Investigation of Effects of Acid Citrate Dextrose and EDTA on Ability To Quantitatively Culture Human Immunodeficiency Virus. J. Clin. Microbiol. 38: 3522-3522 [Full Text]  
  • Helbert, M., Breuer, J. (2000). Monitoring patients with HIV disease. J. Clin. Pathol. 53: 266-272 [Full Text]  
  • Fiscus, S. A., Chakraborty, H., Shepard, R., Goodman, M. (2000). Comparison of Blood Collected in Acid-Citrate-Dextrose and EDTA for Use in Human Immunodeficiency Virus Peripheral Blood Mononuclear Cell Cultures. J. Clin. Microbiol. 38: 858-860 [Abstract] [Full Text]  
  • Witt, D. J., Kemper, M., Stead, A., Ginocchio, C. C., Caliendo, A. M. (2000). Relationship of Incremental Specimen Volumes and Enhanced Detection of Human Immunodeficiency Virus Type 1 RNA with Nucleic Acid Amplification Technology. J. Clin. Microbiol. 38: 85-89 [Abstract] [Full Text]  
  • Aguilera, A., Vela, A., Treviño, M., Varela, E., Seoane, R., Regueiro, B. J. (2000). Obtaining Unacceptable Results in Assays for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma Samples. J. Clin. Microbiol. 38: 472-473 [Full Text]  
  • Kirstein, L. M., Mellors, J. W., Rinaldo, C. R. Jr., Margolick, J. B., Giorgi, J. V., Phair, J. P., Dietz, E., Gupta, P., Sherlock, C. H., Hogg, R., Montaner, J. S. G., Muñoz, A. (1999). Effects of Anticoagulant, Processing Delay, and Assay Method (Branched DNA versus Reverse Transcriptase PCR) on Measurement of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma. J. Clin. Microbiol. 37: 2428-2433 [Abstract] [Full Text]  
  • Lew, J., Reichelderfer, P., Fowler, M., Bremer, J., Carrol, R., Cassol, S., Chernoff, D., Coombs, R., Cronin, M., Dickover, R., Fiscus, S., Herman, S., Jackson, B., Kornegay, J., Kovacs, A., McIntosh, K., Meyer, W., Michael, N., Mofenson, L., Moye, J., Quinn, T., Robb, M., Vahey, M., Weiser, B., Yeghiazarian, T. (1998). Determinations of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma: Reassessment of Parameters Affecting Assay Outcome. J. Clin. Microbiol. 36: 1471-1479 [Full Text]